Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine

Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against infectious diseases, today announced a partnership with Dutch Leiden University Medical Center (LUMC) to develop and evaluate a new nasal spray corona vaccine in a clinical phase I/II study.

from Breaking World Pharma News https://ift.tt/3eW9d9E